Coronavirus Ecology and Evolution
Coronavirus (COVID-19) is a zoonotic disease. Zoonotic diseases are transmitted between creatures and humans. Diseases transmitted from animals to humans pose a significant threat to human health. COVID-19 is a reminder that human health and environmental health are closely related. There are about 8 million species of living things on earth, of which humans are just one. These include 1.7 million undetected viruses that are known to infect humans in mammals and waterfowl. If we do not take preventive measures now, any one of these will be transferred to humans. Greenhouse gas emissions — primarily caused by the burning of fossil fuels — cause changes in temperature and humidity that directly affect microbial survival.
Patients with suspicious common clinical signs of Kovid-19 such as fever, cough, sore throat, loss of taste or smell, malaise and myalgia should be tested immediately for SARS-CoV-2. In addition to symptomatic patients, patients with typical symptoms of Kovid-19 or anyone with high-risk exposure to SARS-CoV-2 should be tested for SARS-CoV-2 infection even if they have no symptoms.
Related Conference of Coronavirus Ecology and Evolution
5th International Conference on Microbiology and Infectious Diseases
11th International Conference on Infectious and Rare Diseases
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
20th World Conference on Infectious Diseases, Prevention and Control
8th Annual Congress on Bacterial, Viral and Infectious Diseases
Coronavirus Ecology and Evolution Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- Alcohol and Drug Use - STD-HIV AIDS-2025 (USA)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Clinical Research and Case Reports - STD-HIV AIDS-2025 (USA)
- Co-infections Associated with STDs - STD-HIV AIDS-2025 (USA)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Diagnosis and Treatment - STD-HIV AIDS-2025 (USA)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Epidemiology - Infection Prevention 2025 (UK)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV and Women's Health Issues - STD-HIV AIDS-2025 (USA)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Neuro Infections - Infection Prevention 2025 (UK)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Pediatric HIV - STD-HIV AIDS-2025 (USA)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Public Health - STD-HIV AIDS-2025 (USA)
- Recent Advancements - STD-HIV AIDS-2025 (USA)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- Sexual Health - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases - STD-HIV AIDS-2025 (USA)
- Testing and Health Monitoring - STD-HIV AIDS-2025 (USA)
- Transmission and Prevention - STD-HIV AIDS-2025 (USA)
- Vaccines and People with HIV - STD-HIV AIDS-2025 (USA)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)